LV3‐shRNA showed a significant effect in lowering the mean value of body weight, serum creatinine and urinary albumin/creatinine ratio in DN mice (P < 0.05), indicating that down‐regulation of ChemR23 is effective in alleviating DN symptoms. Here, CMKLR1 is linked to liver dysplastic nodule.